References
- Wong, M. L. & Licinio, J. Research and treatment approaches to depression. Nat Rev Neurosci 2:343-351 (2001) https://doi.org/10.1038/35072566
- Porsolt, R. D., Anton, G., Blavet, N. & Jalfre, M. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 47:379-391 (1978) https://doi.org/10.1016/0014-2999(78)90118-8
- Lucki, I. The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behav Pharmacol 8:523-532 (1997) https://doi.org/10.1097/00008877-199711000-00010
- Borsini, F. & Meli, A. Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology (Berl) 94:147-160 (1988)
- Detke, M. J., Rickels, M. & Lucki, I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berl) 121:66-72 (1995) https://doi.org/10.1007/BF02245592
- Sheehan, T. P., Chambers, R. A. & Russell, D. S. Regulation of affect by the lateral septum: implications for neuropsychiatry. Brain Res Brain Res Rev 46:71-117 (2004) https://doi.org/10.1016/j.brainresrev.2004.04.009
- Bali, B., Erdelyi, F., Szabo, G. & Kovacs, K. J. Visualization of stress-responsive inhibitory circuits in the GAD65-eGFP transgenic mice. Neurosci Lett 380:60-65 (2005) https://doi.org/10.1016/j.neulet.2005.01.014
- Melia, K. R., Ryabinin, A. E., Schroeder, R., Bloom, F. E. & Wilson, M. C. Induction and habituation of immediate early gene expression in rat brain by acute and repeated restraint stress. J Neurosci 14:5929-5938 (1994) https://doi.org/10.1523/JNEUROSCI.14-10-05929.1994
- Ons, S., Marti, O. & Armario, A. Stress-induced activation of the immediate early gene Arc (activity-regulated cytoskeleton-associated protein) is restricted to telencephalic areas in the rat brain: relationship to c-fos mRNA. J Neurochem 89:1111-1118 (2004) https://doi.org/10.1111/j.1471-4159.2004.02396.x
- Trneckova, L., Rotllant, D., Klenerova, V., Hynie, S. & Armario, A. Dynamics of immediate early gene and neuropeptide gene response to prolonged immobilization stress: evidence against a critical role of the termination of exposure to the stressor. J Neurochem 100:905-914 (2007) https://doi.org/10.1111/j.1471-4159.2006.04278.x
- Duncan, G. E., Johnson, K. B. & Breese, G. R. Topographic patterns of brain activity in response to swim stress: assessment by 2-deoxyglucose uptake and expression of Fos-like immunoreactivity. J Neurosci 13:3932-3943 (1993) https://doi.org/10.1523/JNEUROSCI.13-09-03932.1993
- Muigg, P. et al. Altered brain activation pattern associated with drug-induced attenuation of enhanced depression-like behavior in rats bred for high anxiety. Biol Psychiatry 61:782-796 (2007) https://doi.org/10.1016/j.biopsych.2006.08.035
- Stemmelin, J., Lukovic, L., Salome, N. & Griebel, G. Evidence that the lateral septum is involved in the antidepressant-like effects of the vasopressin V1b receptor antagonist, SSR149415. Neuropsychopharmacology 30:35-42 (2005) https://doi.org/10.1038/sj.npp.1300562
- Hajos, M., Fleishaker, J. C., Filipiak-Reisner, J. K., Brown, M. T. & Wong, E. H. The selective norepinephrine reuptake inhibitor antidepressant reboxetine: pharmacological and clinical profile. CNS Drug Rev 10:23-44 (2004) https://doi.org/10.1111/j.1527-3458.2004.tb00002.x
- Willner, P., Muscat, R. & Papp, M. Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neurosci Biobehav Rev 16:525-534 (1992) https://doi.org/10.1016/S0149-7634(05)80194-0
- Cryan, J. F., Markou, A. & Lucki, I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 23:238-245 (2002) https://doi.org/10.1016/S0165-6147(02)02017-5
- Connor, T. J., Kelliher, P., Harkin, A., Kelly, J. P. & Leonard, B. E. Reboxetine attenuates forced swim test-induced behavioural and neurochemical alterations in the rat. Eur J Pharmacol 379:125-133 (1999) https://doi.org/10.1016/S0014-2999(99)00492-6
- Harkin, A. et al. Activity and onset of action of reboxetine and effect of combination with sertraline in an animal model of depression. Eur J Pharmacol 364:123-132 (1999) https://doi.org/10.1016/S0014-2999(98)00838-3
- Wong, E. H. et al. Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor. Biol Psychiatry 47:818-829 (2000) https://doi.org/10.1016/S0006-3223(99)00291-7
- Cryan, J. F., Page, M. E. & Lucki, I. Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test. Eur J Pharmacol 436:197-205 (2002) https://doi.org/10.1016/S0014-2999(01)01628-4
- Kinnunen, A. et al. N-syndecan and HB-GAM (heparin-binding growth-associated molecule) associate with early axonal tracts in the rat brain. Eur J Neurosci 10:635-648 (1998)
- Hida, H. et al. Pleiotrophin exhibits a trophic effect on survival of dopaminergic neurons in vitro. Eur J Neurosci 17:2127-2134 (2003) https://doi.org/10.1046/j.1460-9568.2003.02661.x
- Jung, C. G. et al. Pleiotrophin mRNA is highly expressed in neural stem (progenitor) cells of mouse ventral mesencephalon and the product promotes production of dopaminergic neurons from embryonic stem cell-derived nestin-positive cells. FASEB J 18:1237-1239 (2004) https://doi.org/10.1096/fj.03-0927fje
- Ezquerra, L. et al. Pleiotrophin is a major regulator of the catecholamine biosynthesis pathway in mouse aorta. Biochem Biophys Res Commun 323:512-517 (2004) https://doi.org/10.1016/j.bbrc.2004.08.121
- Tsao, P. & von Zastrow, M. Downregulation of G protein-coupled receptors. Curr Opin Neurobiol 10:365-369 (2000) https://doi.org/10.1016/S0959-4388(00)00096-9
- Lin, L. et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98:365-376 (1999) https://doi.org/10.1016/S0092-8674(00)81965-0
- Terao, A., Apte-Deshpande, A., Morairty, S., Freund, Y. R. & Kilduff, T. S. Age-related decline in hypocretin (orexin) receptor 2 messenger RNA levels in the mouse brain. Neurosci Lett 332:190-194 (2002) https://doi.org/10.1016/S0304-3940(02)00953-9
- Sunter, D. et al. Orexins: effects on behavior and localisation of orexin receptor 2 messenger ribonucleic acid in the rat brainstem. Brain Res 907:27-34 (2001) https://doi.org/10.1016/S0006-8993(01)02344-7
- Blanco, M. et al. Cellular localization of orexin receptors in human adrenal gland, adrenocortical adenomas and pheochromocytomas. Regul Pept 104:161-165 (2002) https://doi.org/10.1016/S0167-0115(01)00359-7
- Walling, S. G., Nutt, D. J., Lalies, M. D. & Harley, C. W. Orexin-A infusion in the locus ceruleus triggers norepinephrine (NE) release and NE-induced longterm potentiation in the dentate gyrus. J Neurosci 24:7421-7426 (2004) https://doi.org/10.1523/JNEUROSCI.1587-04.2004
- Todd, K. G., McManus, D. J. & Baker, G. B. Chronic administration of the antidepressants phenelzine, desipramine, clomipramine, or maprotiline decreases binding to 5-hydroxytryptamine2A receptors without affecting benzodiazepine binding sites in rat brain. Cell Mol Neurobiol 15:361-370 (1995) https://doi.org/10.1007/BF02089946
- Wohlpart, K. L. & Molinoff, P. B. Regulation of levels of 5-HT2A receptor mRNA. Ann N Y Acad Sci 861:128-135 (1998) https://doi.org/10.1111/j.1749-6632.1998.tb10183.x
- Hopwood, S. E. & Stamford, J. A. Noradrenergic modulation of serotonin release in rat dorsal and median raphe nuclei via alpha (1) and alpha (2A) adrenoceptors. Neuropharmacology 41:433-442 (2001) https://doi.org/10.1016/S0028-3908(01)00087-9
- Patel, J. G., Bartoszyk, G. D., Edwards, E. & Ashby, C. R., Jr. The highly selective 5-hydroxytryptamine (5-HT)2A receptor antagonist, EMD 281014, significantly increases swimming and decreases immobility in male congenital learned helpless rats in the forced swim test. Synapse 52:73-75 (2004) https://doi.org/10.1002/syn.10308
- Sibille, E. et al. Antisense inhibition of 5-hydroxytryptamine2a receptor induces an antidepressant-like effect in mice. Mol Pharmacol 52:1056-1063 (1997) https://doi.org/10.1124/mol.52.6.1056
- Beck, B., Richy, S., Dimitrov, T. & Stricker-Krongrad, A. Opposite regulation of hypothalamic orexin and neuropeptide Y receptors and peptide expressions in obese Zucker rats. Biochem Biophys Res Commun 286:518-523 (2001) https://doi.org/10.1006/bbrc.2001.5420
- Widdowson, P. S. & Halaris, A. E. Chronic desipramine treatment reduces regional neuropeptide Y binding to Y2-type receptors in rat brain. Brain Res 539:196-202 (1991) https://doi.org/10.1016/0006-8993(91)91621-7
- Goyal, S. N., Kokare, D. M., Chopde, C. T. & Subhedar, N. K. Alpha-melanocyte stimulating hormone antagonizes antidepressant-like effect of neuropeptide Y in Porsolt's test in rats. Pharmacol Biochem Behav 85:369-377 (2006) https://doi.org/10.1016/j.pbb.2006.09.004
- Redrobe, J. P., Dumont, Y., Fournier, A. & Quirion, R. The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test. Neuropsychopharmacology 26:615-624 (2002) https://doi.org/10.1016/S0893-133X(01)00403-1
- Banki, C. M., Bissette, G., Arato, M. & Nemeroff, C. B. Elevation of immunoreactive CSF TRH in depressed patients. Am J Psychiatry 145:1526-1531 (1988) https://doi.org/10.1176/ajp.145.12.1526
- Kirkegaard, C., Faber, J., Hummer, L. & Rogowski, P. Increased levels of TRH in cerebrospinal fluid from patients with endogenous depression. Psychoneuroendocrinology 4:227-235 (1979) https://doi.org/10.1016/0306-4530(79)90006-4
- Joffe, R. T. & Marriott, M. Thyroid hormone levels and recurrence of major depression. Am J Psychiatry 157:1689-1691 (2000) https://doi.org/10.1176/appi.ajp.157.10.1689
- Bauer, M., Hellweg, R., Graf, K. J. & Baumgartner, A. Treatment of refractory depression with high-dose thyroxine. Neuropsychopharmacology 18:444-455 (1998) https://doi.org/10.1016/S0893-133X(97)00181-4
- Rudas, S., Schmitz, M., Pichler, P. & Baumgartner, A. Treatment of refractory chronic depression and dysthymia with high-dose thyroxine. Biol Psychiatry 45:229-233 (1999) https://doi.org/10.1016/S0006-3223(98)00033-X
- Lifschytz, T., Shalom, G., Lerer, B. & Newman, M. E. Sex-dependent effects of fluoxetine and triiodothyronine in the forced swim test in rats. Eur Neuropsychopharmacol 16:115-121 (2006) https://doi.org/10.1016/j.euroneuro.2005.07.003
- Racz, B. & Weinberg, R. J. Spatial organization of cofilin in dendritic spines. Neuroscience 138:447-456 (2006) https://doi.org/10.1016/j.neuroscience.2005.11.025
- Arber, S. et al. Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase. Nature 393:805-809 (1998) https://doi.org/10.1038/31729
- Yang, N. et al. Cofilin phosphorylation by LIMkinase 1 and its role in Rac-mediated actin reorganization. Nature 393:809-812 (1998) https://doi.org/10.1038/31735
- Yoshikawa, T. Approach to depressogenic genes from genetic analyses of animal models. Seishin Shinkeigaku Zasshi 106:1037-1044 (2004)
- McClung, C. A. & Nestler, E. J. Neuroplasticity mediated by altered gene expression. Neuropsychopharmacology 33:3-17 (2008) https://doi.org/10.1038/sj.npp.1301544
- Cassel, S. et al. Fluoxetine and cocaine induce the epigenetic factors MeCP2 and MBD1 in adult rat brain. Mol Pharmacol 70:487-492 (2006) https://doi.org/10.1124/mol.106.022301
- Tsankova, N. M. et al. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 9:519-525 (2006) https://doi.org/10.1038/nn1659